Details
Stereochemistry | RACEMIC |
Molecular Formula | C22H34ClN3O2 |
Molecular Weight | 407.977 |
Optical Activity | ( + / - ) |
Defined Stereocenters | 0 / 1 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
CC(C)N(CCC(CCN1CCCCC1)(C(N)=O)C2=C(Cl)C=CC=C2)C(C)=O
InChI
InChIKey=GTEPPJFJSNSNIH-UHFFFAOYSA-N
InChI=1S/C22H34ClN3O2/c1-17(2)26(18(3)27)16-12-22(21(24)28,19-9-5-6-10-20(19)23)11-15-25-13-7-4-8-14-25/h5-6,9-10,17H,4,7-8,11-16H2,1-3H3,(H2,24,28)
Originator
Approval Year
PubMed
Title | Date | PubMed |
---|---|---|
Bidisomide (SC-40230), a new antiarrhythmic agent: initial study of tolerability and pharmacokinetics. | 1992 Apr |
|
Metabolism of a novel antiarrhythmic agent, bidisomide, in man: use of high resolution mass spectrometry to distinguish desisopropyl bidisomide from desacetyl bidisomide. | 1995 Sep |
|
Reduced systemic availability of an antiarrhythmic drug, bidisomide, with meal co-administration: relationship with region-dependent intestinal absorption. | 1998 Feb |
|
Mechanism of compound- and species-specific food effects of structurally related antiarrhythmic drugs, disopyramide and bidisomide. | 1998 Mar |
|
Electrophysiologic effects of an antiarrhythmic agent, bidisomide, on sodium current in isolated rat ventricular myocytes: comparison with mexiletine and disopyramide. | 2001 May |
Sample Use Guides
In Vivo Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/1563207
Intravenous doses ranged from 0.03 to 2.5 mg/kg.
Route of Administration:
Intravenous
Name | Type | Language | ||
---|---|---|---|---|
|
Official Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Code | English | ||
|
Code | English | ||
|
Common Name | English |
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
116078-65-0
Created by
admin on Fri Dec 15 18:39:37 GMT 2023 , Edited by admin on Fri Dec 15 18:39:37 GMT 2023
|
PRIMARY | |||
|
6598
Created by
admin on Fri Dec 15 18:39:37 GMT 2023 , Edited by admin on Fri Dec 15 18:39:37 GMT 2023
|
PRIMARY | |||
|
m2478
Created by
admin on Fri Dec 15 18:39:37 GMT 2023 , Edited by admin on Fri Dec 15 18:39:37 GMT 2023
|
PRIMARY | Merck Index | ||
|
368
Created by
admin on Fri Dec 15 18:39:37 GMT 2023 , Edited by admin on Fri Dec 15 18:39:37 GMT 2023
|
PRIMARY | |||
|
SUB05824MIG
Created by
admin on Fri Dec 15 18:39:37 GMT 2023 , Edited by admin on Fri Dec 15 18:39:37 GMT 2023
|
PRIMARY | |||
|
DTXSID60869599
Created by
admin on Fri Dec 15 18:39:37 GMT 2023 , Edited by admin on Fri Dec 15 18:39:37 GMT 2023
|
PRIMARY | |||
|
100000085901
Created by
admin on Fri Dec 15 18:39:37 GMT 2023 , Edited by admin on Fri Dec 15 18:39:37 GMT 2023
|
PRIMARY | |||
|
2X3Z153A4O
Created by
admin on Fri Dec 15 18:39:37 GMT 2023 , Edited by admin on Fri Dec 15 18:39:37 GMT 2023
|
PRIMARY | |||
|
C166602
Created by
admin on Fri Dec 15 18:39:37 GMT 2023 , Edited by admin on Fri Dec 15 18:39:37 GMT 2023
|
PRIMARY | |||
|
CHEMBL305745
Created by
admin on Fri Dec 15 18:39:37 GMT 2023 , Edited by admin on Fri Dec 15 18:39:37 GMT 2023
|
PRIMARY | |||
|
BB-70
Created by
admin on Fri Dec 15 18:39:37 GMT 2023 , Edited by admin on Fri Dec 15 18:39:37 GMT 2023
|
PRIMARY | |||
|
59798
Created by
admin on Fri Dec 15 18:39:37 GMT 2023 , Edited by admin on Fri Dec 15 18:39:37 GMT 2023
|
PRIMARY |
ACTIVE MOIETY